85 results
6-K
TAK
Takeda Pharmaceutical Co
9 May 24
Current report (foreign)
6:03am
care system and society.
Takeda estimates that efficiencies and savings resulting from the multi-year program, offset by investments in its late-stage
6-K
TAK
Takeda Pharmaceutical Co
9 May 24
Current report (foreign)
6:01am
was offset by the decrease in Neuroscience. Revenue outside of these key business areas decreased mainly due to the decline in sales of AZILVA … generation therapies.
Decrease in revenue of other rare hematology products largely offset the net increase of the above products.
Revenue of Rare
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
9 May 24
Current report (foreign)
6:01am
) partially offset by EOHILIA reversal
Other operating income
Other operating expenses
Includes revaluation of XIIDRA future milestone and EOHILIA milestone … products and FX benefit largely offset by LOE impact (mainly VYVANSE)
Cost of sales
Gross Profit
Reflects revenue growth; Gross margin negatively
6-K
TAK
Takeda Pharmaceutical Co
2 Feb 24
Current report (foreign)
6:16am
”) and Rare Diseases. The increase of these business areas was offset by the decrease in Oncology and Neuroscience. Although the decrease was partially … was partially offset by the decrease of other rare hematology products.
Revenue of Rare Genetics and Other was JPY 355.0 billion (JPY +34.1 billion and +10.6
6-K
TAK
Takeda Pharmaceutical Co
1 Feb 24
Current report (foreign)
6:06am
was offset by the decrease in Oncology and Neuroscience. Although the decrease was partially mitigated by favorable foreign exchange rates … offset by the decrease of other rare hematology products.
Takeda Pharmaceutical Company Limited (4502)
Summary of Financial Statements for the Nine
6-K
EX-99.1
y3i um1gzx
30 Nov 23
Current report (foreign)
6:01am
6-K
anfrzhfi7x 94
30 Oct 23
Current report (foreign)
6:02am
6-K
2nh267tys4cbehhyxpe7
26 Oct 23
Current report (foreign)
6:22am
6-K
dv1g0w0lg
26 Oct 23
Current report (foreign)
6:20am
6-K
8i54sxtz a6
1 Aug 23
Current report (foreign)
6:10am
6-K
bvq6sqb61f
27 Jul 23
Current report (foreign)
6:05am
6-K
EX-99.1
3yls6wmtur
23 Jun 23
Current report (foreign)
6:13am
6-K
EX-99.1
hgedzvan5u8
30 May 23
Current report (foreign)
6:19am
6-K
EX-99.1
ljxtx810q7i1i7p
30 May 23
Current report (foreign)
6:14am
6-K
EX-99.1
cueye0n
30 May 23
Current report (foreign)
6:11am
6-K
pff8b5n01xd5u2wkeo0h
11 May 23
Current report (foreign)
6:07am
6-K
wqg4k
4 Nov 22
Current report (foreign)
6:01am
6-K
4efnekv4 sp
27 Oct 22
Current report (foreign)
6:01am